Sarepta Therapeutics, Inc. SRPT Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s noncash or part noncash acquisition fixed assets acquired1.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s noncash or part noncash acquisition fixed assets acquired1?
- Sarepta Therapeutics, Inc. (SRPT) reported noncash or part noncash acquisition fixed assets acquired1 of $5.95M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s noncash or part noncash acquisition fixed assets acquired1 changed year-over-year?
- Sarepta Therapeutics, Inc.'s noncash or part noncash acquisition fixed assets acquired1 decreased by 79.6% year-over-year, from $29.23M to $5.95M.
- What does noncash or part noncash acquisition fixed assets acquired1 mean?
- Represents the value of property, plant, and equipment acquired through non-cash means, such as debt financing or exchange of assets, rather than direct cash outlays. This metric allows for a more accurate assessment of capital expenditure intensity by including investments not reflected in the cash flow from investing activities. It provides a clearer picture of the company's total asset growth strategy.